BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17379910)

  • 1. Imaging the endometrium in postmenopausal bleeding.
    Sahdev A
    BMJ; 2007 Mar; 334(7594):635-6. PubMed ID: 17379910
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen induced endometrial abnormalities: evaluation by saline infusion sonohysterography.
    Jaeger BM; Grumbach K
    Md Med J; 1997 Sep; 46(8):433-5. PubMed ID: 9294952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Villous papyraceous: an unusual cause of tamoxifen-induced postmenopausal bleeding.
    Oladipo A; Mathew J
    Climacteric; 2006 Jun; 9(3):234-7. PubMed ID: 16766437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
    Cohen I
    Gynecol Oncol; 2001 Aug; 82(2):406-7. PubMed ID: 11531305
    [No Abstract]   [Full Text] [Related]  

  • 5. Hysteroscopy in the diagnosis of postmenopausal bleeding.
    Guruwadayarhalli B; Jones SE; Srinivasan V
    Menopause Int; 2007 Sep; 13(3):132-4. PubMed ID: 17785039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the endometrium of postmenopausal women with transvaginal ultrasonography.
    Bourne TH
    Ultrasound Obstet Gynecol; 1995 Aug; 6(2):75-80. PubMed ID: 8535921
    [No Abstract]   [Full Text] [Related]  

  • 7. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
    Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
    Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some specifics of tamoxifen's effect on the endometrium in menopausal cancer patients].
    Ashtrafian LA; Antonova IB; Chazova NL; Motskobili TA; Babaeva NA; Al'ditskiĭ IA
    Vopr Onkol; 2005; 51(2):200-5. PubMed ID: 16223001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of ultrasonography in diagnosis of atypical endometrial hyperplasia in postmenopausal women].
    Starczewski A; Brodowska A; Strojny K; Puchalski A; Mieczkowska E; Szydłowska I
    Przegl Lek; 2005; 62(4):227-9. PubMed ID: 16229240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transvaginal sonography of the postmenopausal endometrium].
    Curcić A; Segedi D; Belopavlović Z; Petrović D
    Med Pregl; 2000; 53(1-2):59-63. PubMed ID: 10953553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uterine abnormalities in non menopausal women who received tamoxifen for breast cancer adjuvant therapy].
    d'Arailh AS; Michy T; Pioud R; Dravet F; Classe JM
    Gynecol Obstet Fertil; 2007 Dec; 35(12):1215-9. PubMed ID: 18035581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study using transvaginal real-time ultrasound elastography to evaluate the postmenopausal endometrium.
    Neale E; Housden R; Crawford R; Treece G; Sala E; Gee A; Prager R
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):235-6. PubMed ID: 21611992
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients.
    Markovitch O; Tepper R; Fishman A; Shapira J; Aviram R; Cohen I
    Gynecol Oncol; 2004 Dec; 95(3):456-62. PubMed ID: 15581946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Errors in the measurement of endometrial depth using transvaginal sonography in postmenopausal women on tamoxifen: random error is reduced using saline instillation sonography.
    Ballard P; Tetlow R; Richmond I; Killick S; Purdie DW
    Ultrasound Obstet Gynecol; 2000 Apr; 15(4):321-6. PubMed ID: 10895453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
    Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of endovaginal ultrasonography in assessing tamoxifen-associated changes of the endometrium. A prospective study.
    Strauss HG; Wolters M; Methfessel G; Buchmann J; Koelbl H
    Acta Obstet Gynecol Scand; 2000 Aug; 79(8):697-701. PubMed ID: 10949237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
    Cohen I; Altaras MM; Tepper R; Beyth Y
    Gynecol Oncol; 1996 Dec; 63(3):412-4. PubMed ID: 8946882
    [No Abstract]   [Full Text] [Related]  

  • 18. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
    Bertelli G; Valenzano M; Costantini S; Rissone R; Angiolini C; Signorini A; Gustavino C
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):275-7. PubMed ID: 10985880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of endometrial ultrasonography and endometrial histopathology in patients with postmenopausal bleeding.
    Bafna UD; Shashikala P; Nagarathna DS
    J Indian Med Assoc; 2006 Nov; 104(11):627-9. PubMed ID: 17444062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
    Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
    Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.